| 标题 |
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Respiratory medicine 作者:Solomon BJ; Bauer TM; Mok TSK; Liu G; Mazieres J; et al 出版日期:2023/04/01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)